WallStreetZenWallStreetZen

NASDAQ: VOR
Vor Biopharma Inc Stock Ownership - Who owns Vor Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vor Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ra Capital Management LPDirector2025-10-2790,941$28.12
$2.56MSell
Ra Capital Management LPDirector2025-10-2453,345$28.01
$1.49MSell
Ra Capital Management LPDirector2025-10-2376,880$28.01
$2.15MSell
Ra Capital Management LPDirector2025-10-2125,027$28.11
$703.51kSell
Reprogrammed Interchange LLC10% Owner2025-10-21200$30.08
$6.02kSell
Ra Capital Management LPDirector2025-10-2070,366$29.63
$2.08MSell
Ra Capital Management LPDirector2025-10-2013,817$29.63
$409.40kSell
Ra Capital Management LPDirector2025-10-206,553$30.12
$197.38kSell
Ra Capital Management LPDirector2025-10-201,287$30.12
$38.76kSell
Reprogrammed Interchange LLC10% Owner2025-10-2011,616$30.05
$349.10kSell

1 of 9

VOR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VOR insiders and whales buy or sell their stock.

VOR Shareholders

What type of owners hold Vor Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP625.91%39,646,039$1.07BInstitution
Sandesh Mahatme219.17%13,882,750$373.79MInsider
5am Venture Management LLC100.44%6,361,723$171.29MInstitution
Fmr LLC33.04%2,092,686$56.35MInstitution
Vanguard Group Inc30.24%1,915,606$51.58MInstitution
Kush Parmar27.89%1,766,634$47.57MInsider
5am Ventures VI LP27.89%1,766,634$47.57MInsider
Ubs Group Ag24.18%1,531,636$41.24MInstitution
Ra Capital Management LP18.63%1,180,060$31.77MInsider
Reprogrammed Interchange LLC18.42%1,166,909$31.42MInsider

1 of 3

VOR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VOR71.68%28.32%Net SellingNet Selling
TNXP8.29%91.71%Net BuyingNet Buying
SAVA25.35%73.20%Net BuyingNet Buying
ALEC59.85%40.15%Net SellingNet Selling
MIST13.90%15.58%
View Top Biotech Stocks

Vor Biopharma Stock Ownership FAQ

Who owns Vor Biopharma?

Vor Biopharma (NASDAQ: VOR) is owned by 900.31% institutional shareholders, 355.68% Vor Biopharma insiders, and 0.00% retail investors. Sandesh Mahatme is the largest individual Vor Biopharma shareholder, owning 13.88M shares representing 219.17% of the company. Sandesh Mahatme's Vor Biopharma shares are currently valued at $354.01M.

If you're new to stock investing, here's how to buy Vor Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.